Lipitor Outsold the Entire US Recording Industry In 2009

This has to be one of the more bizarre stats to surface in recent months.

It turns out that sales of anti-cholesterol drug Lipitor actually eclipsed the entire recorded music industry last year in the US.   Take a look:

*2009 US sales of recorded music: $4.6 billion
(source: IFPI’s Recording Industry In Numbers)

*2009 sales of Liptor (US): $5.4 billion
(source: Pfizer financial filings)